GENTEX CORP
For the period ended Sep 30, 2025. Filed Nov 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 7, 2025
GNTX$19.42-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Comprehensive Income
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Nine Months Ended September 30, 2025 and 2024
| 2025 | 2024 | |
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net income from consolidated operations | $291,411,199 | $316,820,194 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 78,808,967 | 70,887,294 |
| Gain on disposal of assets | (161,501) | (1,279,049) |
| Loss on disposal of assets | 13,243 | 48,618 |
| Gain on sale of investments and technology investment income | (1,637,823) | (4,736,312) |
| Loss on sale of investments and technology investment losses | 6,630,483 | 14,839,974 |
| Reserve for credit losses | 4,778,334 | — |
| Deferred income taxes | (5,832,023) | (9,970,207) |
| Stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock | 26,596,685 | 30,936,895 |
| Impairment charge | 8,376,148 | — |
| Change in operating assets and liabilities: | ||
| Accounts receivable, net | (30,771,806) | (34,528,140) |
| Inventories | 35,148,302 | (46,837,992) |
| Prepaid expenses and other | (6,400,676) | (2,616,370) |
| Accounts payable | 52,627,156 | (8,976,998) |
| Accrued liabilities, excluding dividends declared | 2,040,885 | 19,229,845 |
| Net cash provided by operating activities | 461,627,573 | 343,817,752 |
| CASH FLOWS USED FOR INVESTING ACTIVITIES: | ||
| Activity in investments: | ||
| Sales proceeds | 71,903,080 | 35,059,971 |
| Maturities and calls | 1,655,000 | 10,260,000 |
| Purchases | (16,267,120) | (83,764,695) |
| Plant and equipment additions | (103,418,837) | (102,966,564) |
| Proceeds from sale of plant and equipment | 259,111 | 142,400 |
| Acquisition of businesses, net of cash acquired | (156,291,615) | — |
| Loans to technology investment partners | (14,199,157) | — |
| Increase in other assets | (925,381) | (5,614,129) |
| Net cash used for investing activities | (217,284,919) | (146,883,017) |
| CASH FLOWS USED FOR FINANCING ACTIVITIES: | ||
| Issuance of common stock from stock plan transactions | 13,338,052 | 24,024,353 |
| Cash dividends paid | (80,586,484) | (83,145,216) |
| Repurchases of common stock | (229,023,565) | (184,609,148) |
| Net cash used for financing activities | (296,271,997) | (243,730,011) |
| NET DECREASE IN CASH, CASH EQUIVALENTS, and RESTRICTED CASH | (51,929,343) | (46,795,276) |
| CASH, CASH EQUIVALENTS, and RESTRICTED CASH, beginning of period | 233,318,766 | 226,435,019 |
| CASH, CASH EQUIVALENTS, and RESTRICTED CASH, end of period | $181,389,423 | $179,639,743 |
| Reconciliation of cash, cash equivalents and restricted cash to the Unaudited Condensed Consolidated Balance Sheets: | ||
| Balance as of | ||
| September 30, 2025 | December 31, 2024 | |
| Cash and cash equivalents | $178,589,422 | $233,318,766 |
| Restricted cash included in Prepaid expenses and other | 2,800,001 | — |
| $181,389,423 | $233,318,766 | |
| Nine months ended September 30 | ||
|---|---|---|
| SUPPLEMENTAL CASH FLOW DATA | 2025 | 2024 |
| Non-cash investing and financing activities: | ||
| Change in property and equipment in accounts payable and accrued expenses and other current liabilities | $12,433,422 | $(4,115,011) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.